Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer
NCT01163396Phase 2Completed
- Sponsor
- Gruppo Oncologico Nord Ovest
- Start
- Jul 2007
- Primary completion
- Apr 2009
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of bevacizumab in metastatic colorectal cancer (mCRC), sponsored by Gruppo Oncologico Nord Ovest. Started Jul 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01163396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01163396.